TLSI (TriSalus Life Sciences) Inventory Turnover: 0.36 (As of Mar. 2026)

What is TriSalus Life Sciences Inventory Turnover?

TriSalus Life Sciences TLSI +3.80% 29 Inventory Turnover is 0.36 as of Mar. 2026. GuruFocus rates TLSI with a GF Score™ of 29/100 and a GF Value™ of $4.31 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. TriSalus Life Sciences's Cost of Goods Sold for the three months ended in Mar. 2026 was $1.23 Mil. TriSalus Life Sciences's Average Total Inventories for the quarter that ended in Mar. 2026 was $3.43 Mil. TriSalus Life Sciences's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.36.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. TriSalus Life Sciences's Days Inventory for the three months ended in Mar. 2026 was 254.28.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. TriSalus Life Sciences's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.39.

TriSalus Life Sciences (NAS:TLSI) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

TriSalus Life Sciences's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	3.4275	/	1.23	*	365 / 4
	=	254.28

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

TriSalus Life Sciences's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	3.4275	/	8.899
	=	0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

TriSalus Life Sciences Inventory Turnover Related Terms

TriSalus Life Sciences Inventory Turnover Historical Data

* Premium members only.

The historical data trend for TriSalus Life Sciences's Inventory Turnover can be seen below:

TriSalus Life Sciences Inventory Turnover Chart

TriSalus Life Sciences Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

0.92

1.63

1.30

1.24

1.96

TriSalus Life Sciences Quarterly Data
	Dec21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial												0.36	0.45	0.54	0.55	0.36

29GF Score

TriSalus Life Sciences Inc TLSI

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

TriSalus Life Sciences Inventory Turnover Calculation

TriSalus Life Sciences's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	6.965	/ (	(4.048	+	3.077)	/	2 )
=	6.965	/	3.5625
=	1.96

TriSalus Life Sciences's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	1.23	/ (	(3.077	+	3.778)	/	2 )
=	1.23	/	3.4275
=	0.36

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.36 mean?

TriSalus Life Sciences (TLSI) has a Inventory Turnover of 0.36 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on TriSalus Life Sciences and its competitors.

Is TriSalus Life Sciences' Inventory Turnover too high?

TriSalus Life Sciences' current Inventory Turnover is 0.36. Overall, TriSalus Life Sciences has a GF Score™ of 29/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does TriSalus Life Sciences' Inventory Turnover compare to TMCI and LAB?

TriSalus Life Sciences' Inventory Turnover of 0.36 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Medical Devices & Instruments company?

A good Inventory Turnover depends on the Medical Devices & Instruments industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on TriSalus Life Sciences and its competitors. TriSalus Life Sciences's current Inventory Turnover is 0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is TriSalus Life Sciences stock overvalued right now?

Based on GuruFocus' analysis, TriSalus Life Sciences (TLSI) is currently considered Modestly Undervalued. The stock's GF Value™ is $4.31, compared to a current price of $3.82 — trading 11.4% below its estimated fair value. The current Inventory Turnover is 0.36. TriSalus Life Sciences' overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For TriSalus Life Sciences (TLSI), the current Inventory Turnover is 0.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TriSalus Life Sciences (TLSI) Overvalued in 2026?

Based on GuruFocus' analysis, TriSalus Life Sciences stock appears to be undervalued. The current stock price of $3.82 is trading 11.4% below its estimated GF Value™ of $4.31. GuruFocus considers TriSalus Life Sciences to be Modestly Undervalued.

Key valuation signals for TLSI:

Inventory Turnover: 0.36
GF Value™: $4.31 vs. price of $3.82 (11.4% below fair value)
GF Score™: 29/100 with 4 warning signs

No single metric tells the full story. See the TLSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TriSalus Life Sciences Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies TMCI LAB SENS SGHT MASS ELMD CATX RXST CV LUCD ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Address 6272 W. 91st Avenue, Westminster, CO, USA, 80031

Website https://www.trisaluslifesci.com

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

29GF Score

Get the complete analysis for TLSI

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.82

Price

$4.31

GF Value

View TLSI Analysis

See Inventory Turnover data for all stocks →